Print Page   |   Contact Us   |   Sign In   |   Join ISSX
Workshop: The Role of Drug Metabolism in Immune-Mediated Drug Toxicity
View Registrations Tell a Friend About This EventTell a Friend
Workshop: The Role of Drug Metabolism in Immune-Mediated Drug Toxicity

The Role of Drug Metabolism in Immune-Mediated Drug Toxicity: Molecular, Clinical and Mechanistic Aspects Jointly organized by the New England Drug Metabolism Discussion Group and the International Society for the Study of Xenobiotics

4/17/2013 to 4/19/2013
When: 4/17/2013
Where: Boston Marriott Cambridge
2 Cambridge Center
Cambridge, Massachusetts  02142
United States
Contact: ISSX

« Go to Upcoming Event List  

Joint NEDMDG/ISSX Workshop:

The Role of Drug Metabolism in Immune-Mediated Drug Toxicity: Molecular, Clinical and Mechanistic Aspects

Organized by the New England Drug Metabolism Discussion Group and the International Society for the Study of Xenobiotics

Boston Marriott Cambridge ~ April 17-19, 2013


Pre-Workshop: The pre-workshop is designed to provide important background for three focus areas of the main workshop, the formation of reactive intermediates from drugs, the adaptive immune system and the innate immune system. The composition, function and consequences of these biological processes are complex and will not be covered in detail in the main workshop. The pre-workshop is ideal for drug metabolism scientists who wish to have more background information on the immune system and immunologists who wish to have more background information on drug metabolism systems.

Workshop: Idiosyncratic drug induced liver injury (IDILI) is a significant cause of morbidity and mortality. IDILI events can derail clinical drug development programs and lead to drug withdrawal. However, the underlying mechanisms are currently poorly understood. There is growing evidence that the immune system plays an important role in mediating or modulating some forms of IDILI. This workshop will explore the latest advances in understanding the roles of bioactivation, adaptive immunity, innate immunity and cellular signaling in IDILI. This workshop will be of interest to those in the fields of pharmacokinetics, drug metabolism, drug safety assessment and immunology. This workshop will be of interest to those in the fields of pharmacokinetics, drug metabolism, drug safety assessment and immunology.
   

Thank you to all who attended the workshop April 17-19, 2013!

Workshop Organizing Committee

  • Charles Crespi, Corning Life Sciences, Chair
  • Thomas Baillie, University of Washington
  • Radford Decker, Sunovion
  • Chandra Prakash, Biogen Idec
  • Robert Roth, Michigan State University
  • Steven R. Tannenbaum, Massachusetts Institute of Technology
  • Jack Uetrecht, University of Toronto
  • Nancy Wong, Eisai Inc.
  • Zhiyang Zhao, Amgen

Association Management Software Powered by YourMembership.com®  ::  Legal